Objective: We sought to evaluate the efficacy and safety of vildagliptin, a new dipeptidyl peptidase-4 inhibitor, added to metformin during 24 weeks of treatment in patients with type 2 diabetes.

In the group receiving 100 mg vildagliptin daily and continuing metformin treatment, more than three-quarters of patients experienced a meaningful (41.3%) or marked (37.1%) improvement in glycemic ...

Metformin, a widely used medication for diabetes, helps lower blood sugar by improving how the body uses insulin. Over the years, scientists have explored its potential as a treatment for cancer ...

Along with lifestyle changes, metformin can help you get your blood sugar, also called blood glucose, under control. If your blood sugar is not controlled, metformin may not be working for you, and ...

Background: Metformin, a commonly used antidiabetic medication, is available in both an immediate-release (IR) formulation and a long-acting formulation (metformin extended-release; XR). Objective: We ...